STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.

Revenue
+8.79%
EPS
+12.8%
Free cash flow
+43.6%
Total debt
−0.21%

Quarter to September 2026, against a year earlier

252.70 1.42 −0.56%
Market cap
$24.8B
P/E
30.0×
Fwd P/E
25.1×
Dividend yield
1.02%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100
Sep '26 From the 10-Q filed 5 Nov Jun '26 Mar '26 Dec '25 Older periods
ROE
11.57% 11.35% 11.33% 10.41%

+8 more TTM periods

Piotroski F-Score
8 8 9 9
ROA
7.83% 7.62% 7.49% 6.87%
ROIC
8.47% 8.27% 7.92% 7.24%
Return on Tangible Assets
23.90% 24.14% 22.94% 20.24%
Average Days of Receivables
59.51 61.25 67.20 62.04
Free Cash Flow per Share
13.25 9.59 10.01 9.54
Free Cash Flow
1,289.70 936.00 982.90 936.70
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026